Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL

[1]  M. Vingron,et al.  Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks , 2019, Molecular systems biology.

[2]  J. Myklebust,et al.  TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma , 2019, Cancer Immunology Research.

[3]  P. Lichter,et al.  PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia , 2018, Leukemia.

[4]  C. Plass,et al.  From Basic Knowledge to Effective Therapies. , 2018, Cancer cell.

[5]  James E. Bradner,et al.  Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia. , 2018, Cancer cell.

[6]  M. Kramer,et al.  CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia , 2018, The Journal of clinical investigation.

[7]  C. Zhang,et al.  A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  E. Campo,et al.  Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues , 2018, Leukemia.

[9]  Benjamin P. C. Chen,et al.  LILRB4 signaling in leukemia cells mediates T cell suppression and tumor infiltration , 2018, Nature.

[10]  David T. W. Jones,et al.  DNA methylation-based classification of central nervous system tumours , 2018, Nature.

[11]  Andrzej K. Oleś,et al.  Drug-perturbation-based stratification of blood cancer , 2017, The Journal of Clinical Investigation.

[12]  Artemis G. Hatzigeorgiou,et al.  DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions , 2017, Nucleic Acids Res..

[13]  J. Michael Cherry,et al.  The Encyclopedia of DNA elements (ENCODE): data portal update , 2017, Nucleic Acids Res..

[14]  C. Baldari,et al.  Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia. , 2017, Blood.

[15]  L. Pleyer,et al.  TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia , 2017, Oncoimmunology.

[16]  Melanie Boerries,et al.  RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia , 2017, Nature Communications.

[17]  Cheng Cheng,et al.  THE GENOMIC LANDSCAPE OF PEDIATRIC AND YOUNG ADULT T-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA , 2017, Nature Genetics.

[18]  E. Giné,et al.  Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage. , 2016, Cancer cell.

[19]  Lukas Burger,et al.  Pioneering Activity of the C-Terminal Domain of EBF1 Shapes the Chromatin Landscape for B Cell Programming. , 2016, Immunity.

[20]  J. Byrd,et al.  DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia , 2016, Nature Genetics.

[21]  Nathan C. Sheffield,et al.  LOLA: enrichment analysis for genomic region sets and regulatory elements in R and Bioconductor , 2015, Bioinform..

[22]  A. Rosén,et al.  Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways , 2015, Oncotarget.

[23]  J. Byrd,et al.  Epigenetic silencing of miR‐708 enhances NF‐κB signaling in chronic lymphocytic leukemia , 2015, International journal of cancer.

[24]  Jeroen Krijgsveld,et al.  Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis , 2015 .

[25]  P. Moss,et al.  Perturbation of the normal immune system in patients with CLL. , 2015, Blood.

[26]  Ronald P. Schuyler,et al.  Whole-genome fingerprint of the DNA methylome during human B cell differentiation , 2015, Nature Genetics.

[27]  A. Jauch,et al.  p53-dependent non-coding RNA networks in chronic lymphocytic leukemia , 2015, Leukemia.

[28]  M. Pellegrini,et al.  Pioneer Transcription Factors Target Partial DNA Motifs on Nucleosomes to Initiate Reprogramming , 2015, Cell.

[29]  Kairong Cui,et al.  Division of labor between IRF1 and IRF2 in regulating different stages of transcriptional activation in cellular antiviral activities , 2015, Cell & Bioscience.

[30]  B. Jiang,et al.  Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3. , 2015, World journal of gastroenterology.

[31]  Raphael Gottardo,et al.  Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.

[32]  J. Hackney,et al.  The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. , 2014, Cancer cell.

[33]  R. Eils,et al.  Identification of DNA methylation changes at cis-regulatory elements during early steps of HSC differentiation using tagmentation-based whole genome bisulfite sequencing , 2014, Cell cycle.

[34]  R. Eils,et al.  Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis. , 2014, Cell stem cell.

[35]  Thomas Lengauer,et al.  Comprehensive Analysis of DNA Methylation Data with RnBeads , 2014, Nature Methods.

[36]  Amos Tanay,et al.  Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer. , 2014, Cell reports.

[37]  Andrew W. Greaves,et al.  Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia. , 2014, Blood.

[38]  Ling Wang,et al.  B7‐H3‐mediated tumor immunology: Friend or foe? , 2014, International journal of cancer.

[39]  Satoru Miyano,et al.  Acquired initiating mutations in early hematopoietic cells of CLL patients. , 2014, Cancer discovery.

[40]  E. Kimby,et al.  microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia , 2014, Epigenetics.

[41]  Andreas H. Nuber,et al.  Long-lived intestinal tuft cells serve as colon cancer-initiating cells. , 2014, The Journal of clinical investigation.

[42]  Y. Kwong,et al.  Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia , 2014, Journal of Translational Medicine.

[43]  Y. Kwong,et al.  Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia , 2014, Journal of Translational Medicine.

[44]  George A Calin,et al.  Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia - implications on constitutive activation of NFκB pathway , 2013, Molecular Cancer.

[45]  M. Ferracin,et al.  Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia - implications on constitutive activation of NFκB pathway , 2013, Molecular Cancer.

[46]  S. Armstrong,et al.  Cell of origin determines clinically relevant subtypes of MLL-rearranged AML , 2013, Leukemia.

[47]  T. Zenz.  Exhausting T cells in CLL. , 2013, Blood.

[48]  Y. Kwong,et al.  Epigenetic inactivation of the MIR129-2 in hematological malignancies , 2013, Journal of Hematology & Oncology.

[49]  C. Blanpain.  Tracing the cellular origin of cancer , 2013, Nature Cell Biology.

[50]  H. Clevers,et al.  Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties , 2013, Cell.

[51]  R. Rosenquist,et al.  Uncovering the DNA methylome in chronic lymphocytic leukemia , 2013, Epigenetics.

[52]  Francesco Marabita,et al.  A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data , 2012, Bioinform..

[53]  David T. W. Jones,et al.  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. , 2012, Cancer cell.

[54]  Zachary D. Smith,et al.  DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. , 2012, Molecular cell.

[55]  J. Gribben,et al.  Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer. , 2012, Blood.

[56]  Guido Marcucci,et al.  Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  J. Byrd,et al.  Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. , 2012, Cancer research.

[58]  W. Senapedis,et al.  Abstract 3775: Pharmacokinetic (PK) / pharmacodynamic (PD) and efficacy relationship of selective inhibitors of nuclear export (KPT-SINE) , 2012 .

[59]  Bruce J. Aronow,et al.  The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor , 2012, Cell.

[60]  Huanming Yang,et al.  Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor , 2012, Cell.

[61]  Zhaoshi Jiang,et al.  Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[63]  Myong-Hee Sung,et al.  Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. , 2011, Molecular cell.

[64]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[65]  Jane E. Visvader,et al.  Cells of origin in cancer , 2011, Nature.

[66]  O. Elemento,et al.  DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma. , 2010, Blood.

[67]  Chi-Ying F. Huang,et al.  miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..

[68]  V. Salaün,et al.  ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemia. , 2010, Leukemia research.

[69]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[70]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[71]  Michael Hallek,et al.  miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. , 2009, Blood.

[72]  D. Corcoran,et al.  Features of Mammalian microRNA Promoters Emerge from Polymerase II Chromatin Immunoprecipitation Data , 2009, PloS one.

[73]  Hans Clevers,et al.  Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.

[74]  Arturo Alvarez-Buylla,et al.  Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. , 2009, Cancer cell.

[75]  R. Richardson,et al.  Prominin1 marks intestinal stem cells that are susceptible to neoplastic transformation , 2008, Nature.

[76]  M. Capecchi,et al.  Bmi1 is expressed in vivo in intestinal stem cells , 2008, Nature Genetics.

[77]  Shuji Fujita,et al.  Putative promoter regions of miRNA genes involved in evolutionarily conserved regulatory systems among vertebrates , 2008, Bioinform..

[78]  Doron Betel,et al.  The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..

[79]  J. Cheville,et al.  B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. , 2007, Cancer research.

[80]  D. Weisenburger,et al.  Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia , 2007, Cell.

[81]  Yoko Fukuda,et al.  An Evolutionarily Conserved Mechanism for MicroRNA-223 Expression Revealed by MicroRNA Gene Profiling , 2007, Cell.

[82]  D. Oscier,et al.  Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL , 2006, Leukemia.

[83]  J. Byrd,et al.  Epigenetics in chronic lymphocytic leukemia. , 2006, Seminars in oncology.

[84]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[85]  F. Sigaux,et al.  HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). , 2005, Blood.

[86]  M. Grever,et al.  TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  Lisa L. Smith,et al.  Epigenetic Profiling in Chronic Lymphocytic Leukemia Reveals Novel Methylation Targets , 2004, Cancer Research.

[88]  Adrian Wiestner,et al.  ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. , 2003, Blood.

[89]  Olivier Gascuel,et al.  Fast and Accurate Phylogeny Reconstruction Algorithms Based on the Minimum-Evolution Principle , 2002, WABI.

[90]  C. Croce,et al.  Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[91]  D. Catovsky,et al.  TCL1 is activated by chromosomal rearrangement or by hypomethylation , 2001, Genes, chromosomes & cancer.

[92]  S. Clark,et al.  Hypermethylation of E-cadherin in leukemia. , 2000, Blood.

[93]  J. Maunsell,et al.  Consortium , 1978 .

[94]  V. Kuchroo,et al.  Tim-3, Lag-3, and TIGIT. , 2017, Current topics in microbiology and immunology.

[95]  Donghua,et al.  Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3 , 2015 .

[96]  H. Armah.  Malignant Astrocytomas Originate from Neural Stem/Progenitor Cells in a Somatic Tumor Suppressor Mouse Model , 2010 .

[97]  D. Oscier,et al.  ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia. , 2005, Haematologica.

[98]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[99]  W. Eisterer,et al.  CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia. , 2002, Experimental hematology.